Recommended Dosage of Tamsulosin for BPH
The recommended dosage of tamsulosin for treating benign prostatic hyperplasia (BPH) is 0.4 mg once daily, which can be increased to 0.8 mg once daily if there is inadequate response after 2-4 weeks of treatment. 1
Dosing Guidelines
- Tamsulosin should be administered approximately one-half hour following the same meal each day 1
- The capsules should not be crushed, chewed, or opened 1
- For patients who fail to respond to the 0.4 mg dose after 2-4 weeks of treatment, the dose can be increased to 0.8 mg once daily 1
- If tamsulosin administration is discontinued or interrupted for several days, therapy should be restarted with the 0.4 mg once-daily dose 1
Efficacy
- Tamsulosin is an alpha-1A and alpha-1D adrenoceptor antagonist that relaxes prostatic smooth muscle, relieving bladder outlet obstruction 2
- Clinical data support the efficacy of both 0.4 mg and 0.8 mg doses, with the 0.8 mg dose showing slightly greater improvement in symptom scores in some studies 3, 1
- Tamsulosin produces on average a 4-6 point improvement in the AUA Symptom Index, which patients generally perceive as a meaningful change 3
- Improvements in maximum urinary flow rate (Qmax) of 1.1-1.6 mL/sec over placebo have been demonstrated in clinical trials 4, 5
Comparative Efficacy
- Tamsulosin, along with alfuzosin, doxazosin, and terazosin, are all considered appropriate treatment options for patients with lower urinary tract symptoms (LUTS) secondary to BPH 3
- All four agents have similar clinical effectiveness in relieving symptoms 3
- Tamsulosin appears to have a lower probability of orthostatic hypotension but a higher probability of ejaculatory dysfunction compared to other alpha blockers 3
Safety Considerations
The most common adverse events associated with tamsulosin therapy include:
Tamsulosin has a favorable cardiovascular profile compared to non-selective alpha blockers:
Important Clinical Considerations
- Tamsulosin 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) 1
- Patients undergoing cataract surgery should inform their ophthalmologist about tamsulosin use due to the risk of intraoperative floppy iris syndrome 3
- The effectiveness of tamsulosin is maintained for up to 6 years with continued treatment 2